Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Sep 8, 2022
Ardy Arianpour, CEO and Co-Founder of SEQSTER, is breaking down health data silos using their enterprise operating system, which aggregates disparate health data sources, including real-world data, into a single 360-degree view of a patient in real-time. This integrated approach with a Digital Front Door solves many challenges for life sciences, patient engagement, and data interoperability.
Ardy elaborates, "We have achieved nationwide coverage of electronic health records from hospitals and medical groups, as well as genomic DNA labs, wearables, remote patient monitoring sensors, pharmacy data, and even social determinants of health data. And we have this very unique customizable white label approach where SEQSTER provides accelerated access to de-identified tokenized real-time data and comprehensive curated data to address critical needs across the healthcare continuum."
"For about five years, nobody wanted to work with us. We were just building, building, building, being visionary, as we thought. Then the pandemic hit, and Takeda Pharmaceuticals decided to invest in SEQSTER and do a commercial deal with us. From there, we created the SEQSTER data backbone for Takeda to centralize all this health data. And since we pioneered a longitudinal health record and pharma was the first to take a look at our technology, from there, we are able to strike many partnerships. We just exploded in the last two and a half years, I could say."
@SEQSTER #PatientCentric #HealthDataIsMedicine #PatientEngagement #ClinicalTrials #DecentralizedTrials #Interoperability #OutcomesStudies #HEOR #RWD #RWE #SaaS. #SanDiego
Medium Article: Participant Digital Front Door
